14-Year checkup: can a tiny eye implant keep glaucoma at bay?
NCT ID NCT07460791
Summary
This study is checking in on glaucoma patients 8 to 14 years after they received a small implant called Hydrus, which was placed during cataract surgery. The main goal is to see how well the implant continues to lower eye pressure over this very long period and how safe it has been. Researchers are looking at whether patients still need fewer eye-drop medications and if their vision loss has slowed down.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Opthalmology
RECRUITINGMainz, Rhineland-Palatinate, 55131, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.